Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Crime-Scene Compound May Be Newest Tool In Fight Against Malaria, Washington University School of Medicine Study

The compound that detectives spray at crime scenes to find trace amounts of blood may be used one day to kill the malaria parasite. Luminol glows blue when it encounters the hemoglobin in red blood cells. And now, researchers at Washington University School of Medicine in St. Louis have shown that they can trick malaria-infected […]

Read More »

China’s much-hyped healthcare reform drive stuck in first gear

Li Tiantian, a Chinese doctor turned tech entrepreneur, is a leading light of the country’s much-trumpeted healthcare reform drive. His medical networking platform links two million doctors across China and has attracted funding from tech giants like Tencent. DXY is exactly what Beijing has said it’s looking to support after it pinpointed remote healthcare, […]

Read More »

U.S. jury clears Eli Lilly in first Cymbalta withdrawal trial

Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations, the company said. Eli Lily has been sued by roughly 250 plaintiffs who say that the company downplayed warnings about symptoms that can occur when patients […]

Read More »

Amarin Wins Off-Label Case Against FDA

A federal court in New York delivered a setback to the Food and Drug Administration, ruling the agency can’t bar a drug company from marketing a pill for off-label use as long as the claims are truthful. The decision by the federal district court in the Southern District of New York, is the latest of […]

Read More »

California child diagnosed with plague after Yosemite trip

A child who camped in California’s Yosemite National Park has been diagnosed with the plague, the latest of several such infections in the Western United States this year, health officials said. The California child became ill and was hospitalized with the disease, carried by rodents and the fleas that live on them, after visiting the […]

Read More »

CTE: The history and the mystery

BOSTON, Mass., Aug. 7, 2015 /PRNewswire-USNewswire/ — Which athletes are at risk for Chronic Traumatic Encephalopathy (CTE)? Can it be prevented? How is CTE related to sports concussions? When—and how—can CTE be diagnosed? “Our knowledge of CTE is extremely limited,” says Rebekah Mannix, MD, MPH, of Boston Children’s Hospital Emergency Medicine Division and author of a […]

Read More »

J&J gets partial win against Covidien in surgical patent case

Johnson & Johnson subsidiary Ethicon Endo-Surgery Inc will get a second chance to hold rival surgical instrument maker Covidien Plc liable for allegedly infringing two patents on a specialized ultrasonic scalpel that cuts and seals blood vessels. The U.S. Court of Appeals for the Federal Circuit said on Friday a lower court should not have […]

Read More »

New endoscopic, non-surgical bariatric options show promise for treating obesity

DOWNERS GROVE, Ill., Aug. 7, 2015 /PRNewswire-USNewswire/ — The FDA recently approved two new endoscopic bariatric therapies (EBT) for the treatment of obesity. According to the American Society for Gastrointestinal Endoscopy (ASGE), this development provides important new, minimally invasive tools for combatting the obesity epidemic and offers many patients an alternative to surgery.  The ReShape™ Integrated […]

Read More »

Short time between pregnancies linked to osteoporosis

Women who have pregnancies less than a year apart may have a greater risk for osteoporosis later in life than those who wait longer between babies, a study suggests. Researchers compared the reproductive histories of 239 postmenopausal women with osteoporosis to 298 similar women without thinning bones. Pregnancies no more than 12 months apart were […]

Read More »

Amarin scores early victory in fish oil drug marketing lawsuit

A U.S. judge on Friday barred the U.S. Food and Drug Administration from stopping Irish drugmaker Amarin Corp from promoting its fish oil drug for off-label uses, saying the company is protected by the First Amendment. The pharmaceutical industry has been watching this case because it is one of the first to raise a First […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom